Renalytix PLC's shares surged 19% as trading resumed following a £10.5 million fundraise. The money will support the US launch of their kidney disease screening test, kidneyintelX.dkd, through a national healthcare network covering about half of American doctors and hospitals. The company aims to conduct 25,000 tests in 2027, with orders opening in Q1. A shareholder vote later this month will approve an additional £3.9 million funding and new shares issuance scheduled for late September.
Supermicro reported a surprising Q4 gross margin of 17.6%, far above guidance, causing shares to jump. However, management revealed this margin spike was largely due to contract deferrals and one-time factors, not a permanent improvement. They foreca...
American Electric Power (AEP) has increased its full-year 2026 operating earnings guidance to $6.25–$6.55 per share, expecting 7–8% annual growth through 2027 and over 9% compound annual growth through 2030. This optimism is driven by strong demand g...
Compugen Ltd., a clinical-stage cancer immunotherapy company, announced its management will participate in a fireside chat and hold meetings at the H.C. Wainwright 28th Annual Global Investment Conference in New York City on September 14-16, 2026. Th...
SharonAI Holdings Inc., an Australian AI infrastructure company, announced its management team will participate in several key investor conferences across the US and Asia in September 2026. These events include Goldman Sachs Communacopia, Citi Global...
Rua Gold has completed 19,600 meters of drilling at its Auld Creek gold-antimony project in New Zealand, surpassing its target and revealing high-grade mineralization including visible gold. The drilling results support an expanded resource potential...
